世界の医療用バイオマーカー市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Medical Biomarkers Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3610 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、医療用バイオマーカーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（敗血症バイオマーカー、抗生物質耐性バイオマーカー、外傷性脳損傷（TBI）検査バイオマーカー、脳卒中検査バイオマーカー、抗生物質管理バイオマーカー、その他）、用途別市場規模（診断、創薬、個別化医療、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・医療用バイオマーカーの市場動向 ・企業の競争状況、市場シェア ・医療用バイオマーカーの種類別市場規模（敗血症バイオマーカー、抗生物質耐性バイオマーカー、外傷性脳損傷（TBI）検査バイオマーカー、脳卒中検査バイオマーカー、抗生物質管理バイオマーカー、その他） ・医療用バイオマーカーの用途別市場規模（診断、創薬、個別化医療、その他） ・医療用バイオマーカーの北米市場規模2016-2027（アメリカ、カナダ） ・医療用バイオマーカーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・医療用バイオマーカーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・医療用バイオマーカーの中南米市場規模2016-2027（メキシコ、ブラジル） ・医療用バイオマーカーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific、Merck、Bio-Rad Laboratories、QIAGEN、Roche、Danaher Corporation、Siemens Healthcare、Abbott、Agilent Technologies） ・結論

Market Analysis and Insights: Global Medical Biomarkers Market
The global Medical Biomarkers market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Medical Biomarkers market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Medical Biomarkers market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Medical Biomarkers market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Medical Biomarkers market.

Global Medical Biomarkers Scope and Market Size
Medical Biomarkers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Medical Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Other

Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medical Biomarkers Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sepsis Biomarkers
1.2.3 Antibiotic Resistance Biomarkers
1.2.4 Traumatic Brain Injury (TBI) Testing Biomarkers
1.2.5 Stroke Testing Biomarkers
1.2.6 Antibiotic Stewardship Biomarkers
1.2.7 Other
1.3 Market by Application
1.3.1 Global Medical Biomarkers Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Medical Biomarkers Market Perspective (2016-2027)
2.2 Medical Biomarkers Growth Trends by Regions
2.2.1 Medical Biomarkers Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Medical Biomarkers Historic Market Share by Regions (2016-2021)
2.2.3 Medical Biomarkers Forecasted Market Size by Regions (2022-2027)
2.3 Medical Biomarkers Industry Dynamic
2.3.1 Medical Biomarkers Market Trends
2.3.2 Medical Biomarkers Market Drivers
2.3.3 Medical Biomarkers Market Challenges
2.3.4 Medical Biomarkers Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Medical Biomarkers Players by Revenue
3.1.1 Global Top Medical Biomarkers Players by Revenue (2016-2021)
3.1.2 Global Medical Biomarkers Revenue Market Share by Players (2016-2021)
3.2 Global Medical Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Medical Biomarkers Revenue
3.4 Global Medical Biomarkers Market Concentration Ratio
3.4.1 Global Medical Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical Biomarkers Revenue in 2020
3.5 Medical Biomarkers Key Players Head office and Area Served
3.6 Key Players Medical Biomarkers Product Solution and Service
3.7 Date of Enter into Medical Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Medical Biomarkers Breakdown Data by Type
4.1 Global Medical Biomarkers Historic Market Size by Type (2016-2021)
4.2 Global Medical Biomarkers Forecasted Market Size by Type (2022-2027)

5 Medical Biomarkers Breakdown Data by Application
5.1 Global Medical Biomarkers Historic Market Size by Application (2016-2021)
5.2 Global Medical Biomarkers Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Medical Biomarkers Market Size (2016-2027)
6.2 North America Medical Biomarkers Market Size by Type
6.2.1 North America Medical Biomarkers Market Size by Type (2016-2021)
6.2.2 North America Medical Biomarkers Market Size by Type (2022-2027)
6.2.3 North America Medical Biomarkers Market Size by Type (2016-2027)
6.3 North America Medical Biomarkers Market Size by Application
6.3.1 North America Medical Biomarkers Market Size by Application (2016-2021)
6.3.2 North America Medical Biomarkers Market Size by Application (2022-2027)
6.3.3 North America Medical Biomarkers Market Size by Application (2016-2027)
6.4 North America Medical Biomarkers Market Size by Country
6.4.1 North America Medical Biomarkers Market Size by Country (2016-2021)
6.4.2 North America Medical Biomarkers Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Medical Biomarkers Market Size (2016-2027)
7.2 Europe Medical Biomarkers Market Size by Type
7.2.1 Europe Medical Biomarkers Market Size by Type (2016-2021)
7.2.2 Europe Medical Biomarkers Market Size by Type (2022-2027)
7.2.3 Europe Medical Biomarkers Market Size by Type (2016-2027)
7.3 Europe Medical Biomarkers Market Size by Application
7.3.1 Europe Medical Biomarkers Market Size by Application (2016-2021)
7.3.2 Europe Medical Biomarkers Market Size by Application (2022-2027)
7.3.3 Europe Medical Biomarkers Market Size by Application (2016-2027)
7.4 Europe Medical Biomarkers Market Size by Country
7.4.1 Europe Medical Biomarkers Market Size by Country (2016-2021)
7.4.2 Europe Medical Biomarkers Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Medical Biomarkers Market Size (2016-2027)
8.2 Asia-Pacific Medical Biomarkers Market Size by Type
8.2.1 Asia-Pacific Medical Biomarkers Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Medical Biomarkers Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Medical Biomarkers Market Size by Type (2016-2027)
8.3 Asia-Pacific Medical Biomarkers Market Size by Application
8.3.1 Asia-Pacific Medical Biomarkers Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Medical Biomarkers Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Medical Biomarkers Market Size by Application (2016-2027)
8.4 Asia-Pacific Medical Biomarkers Market Size by Region
8.4.1 Asia-Pacific Medical Biomarkers Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Medical Biomarkers Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Medical Biomarkers Market Size (2016-2027)
9.2 Latin America Medical Biomarkers Market Size by Type
9.2.1 Latin America Medical Biomarkers Market Size by Type (2016-2021)
9.2.2 Latin America Medical Biomarkers Market Size by Type (2022-2027)
9.2.3 Latin America Medical Biomarkers Market Size by Type (2016-2027)
9.3 Latin America Medical Biomarkers Market Size by Application
9.3.1 Latin America Medical Biomarkers Market Size by Application (2016-2021)
9.3.2 Latin America Medical Biomarkers Market Size by Application (2022-2027)
9.3.3 Latin America Medical Biomarkers Market Size by Application (2016-2027)
9.4 Latin America Medical Biomarkers Market Size by Country
9.4.1 Latin America Medical Biomarkers Market Size by Country (2016-2021)
9.4.2 Latin America Medical Biomarkers Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Medical Biomarkers Market Size (2016-2027)
10.2 Middle East & Africa Medical Biomarkers Market Size by Type
10.2.1 Middle East & Africa Medical Biomarkers Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Medical Biomarkers Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Medical Biomarkers Market Size by Type (2016-2027)
10.3 Middle East & Africa Medical Biomarkers Market Size by Application
10.3.1 Middle East & Africa Medical Biomarkers Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Medical Biomarkers Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Medical Biomarkers Market Size by Application (2016-2027)
10.4 Middle East & Africa Medical Biomarkers Market Size by Country
10.4.1 Middle East & Africa Medical Biomarkers Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Medical Biomarkers Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Medical Biomarkers Introduction
11.1.4 Thermo Fisher Scientific Revenue in Medical Biomarkers Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Medical Biomarkers Introduction
11.2.4 Merck Revenue in Medical Biomarkers Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Medical Biomarkers Introduction
11.3.4 Bio-Rad Laboratories Revenue in Medical Biomarkers Business (2016-2021)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 QIAGEN
11.4.1 QIAGEN Company Details
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Medical Biomarkers Introduction
11.4.4 QIAGEN Revenue in Medical Biomarkers Business (2016-2021)
11.4.5 QIAGEN Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Medical Biomarkers Introduction
11.5.4 Roche Revenue in Medical Biomarkers Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Details
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation Medical Biomarkers Introduction
11.6.4 Danaher Corporation Revenue in Medical Biomarkers Business (2016-2021)
11.6.5 Danaher Corporation Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Details
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Medical Biomarkers Introduction
11.7.4 Siemens Healthcare Revenue in Medical Biomarkers Business (2016-2021)
11.7.5 Siemens Healthcare Recent Development
11.8 Abbott
11.8.1 Abbott Company Details
11.8.2 Abbott Business Overview
11.8.3 Abbott Medical Biomarkers Introduction
11.8.4 Abbott Revenue in Medical Biomarkers Business (2016-2021)
11.8.5 Abbott Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Details
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Medical Biomarkers Introduction
11.9.4 Agilent Technologies Revenue in Medical Biomarkers Business (2016-2021)
11.9.5 Agilent Technologies Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Medical Biomarkers Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Sepsis Biomarkers
Table 3. Key Players of Antibiotic Resistance Biomarkers
Table 4. Key Players of Traumatic Brain Injury (TBI) Testing Biomarkers
Table 5. Key Players of Stroke Testing Biomarkers
Table 6. Key Players of Antibiotic Stewardship Biomarkers
Table 7. Key Players of Other
Table 8. Global Medical Biomarkers Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Medical Biomarkers Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Medical Biomarkers Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Medical Biomarkers Market Share by Regions (2016-2021)
Table 12. Global Medical Biomarkers Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Medical Biomarkers Market Share by Regions (2022-2027)
Table 14. Medical Biomarkers Market Trends
Table 15. Medical Biomarkers Market Drivers
Table 16. Medical Biomarkers Market Challenges
Table 17. Medical Biomarkers Market Restraints
Table 18. Global Medical Biomarkers Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Medical Biomarkers Market Share by Players (2016-2021)
Table 20. Global Top Medical Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Biomarkers as of 2020)
Table 21. Ranking of Global Top Medical Biomarkers Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Medical Biomarkers Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Medical Biomarkers Product Solution and Service
Table 25. Date of Enter into Medical Biomarkers Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Medical Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Medical Biomarkers Revenue Market Share by Type (2016-2021)
Table 29. Global Medical Biomarkers Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Medical Biomarkers Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Medical Biomarkers Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Medical Biomarkers Revenue Market Share by Application (2016-2021)
Table 33. Global Medical Biomarkers Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Medical Biomarkers Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Medical Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Medical Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Medical Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Medical Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Medical Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Medical Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Medical Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Medical Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Medical Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Medical Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Medical Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Medical Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Medical Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Medical Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Medical Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Medical Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Medical Biomarkers Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Medical Biomarkers Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Medical Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Medical Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Medical Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Medical Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Medical Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Medical Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Medical Biomarkers Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Medical Biomarkers Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Medical Biomarkers Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Medical Biomarkers Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Medical Biomarkers Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Medical Biomarkers Market Size by Country (2022-2027) & (US$ Million)
Table 65. Thermo Fisher Scientific Company Details
Table 66. Thermo Fisher Scientific Business Overview
Table 67. Thermo Fisher Scientific Medical Biomarkers Product
Table 68. Thermo Fisher Scientific Revenue in Medical Biomarkers Business (2016-2021) & (US$ Million)
Table 69. Thermo Fisher Scientific Recent Development
Table 70. Merck Company Details
Table 71. Merck Business Overview
Table 72. Merck Medical Biomarkers Product
Table 73. Merck Revenue in Medical Biomarkers Business (2016-2021) & (US$ Million)
Table 74. Merck Recent Development
Table 75. Bio-Rad Laboratories Company Details
Table 76. Bio-Rad Laboratories Business Overview
Table 77. Bio-Rad Laboratories Medical Biomarkers Product
Table 78. Bio-Rad Laboratories Revenue in Medical Biomarkers Business (2016-2021) & (US$ Million)
Table 79. Bio-Rad Laboratories Recent Development
Table 80. QIAGEN Company Details
Table 81. QIAGEN Business Overview
Table 82. QIAGEN Medical Biomarkers Product
Table 83. QIAGEN Revenue in Medical Biomarkers Business (2016-2021) & (US$ Million)
Table 84. QIAGEN Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Medical Biomarkers Product
Table 88. Roche Revenue in Medical Biomarkers Business (2016-2021) & (US$ Million)
Table 89. Roche Recent Development
Table 90. Danaher Corporation Company Details
Table 91. Danaher Corporation Business Overview
Table 92. Danaher Corporation Medical Biomarkers Product
Table 93. Danaher Corporation Revenue in Medical Biomarkers Business (2016-2021) & (US$ Million)
Table 94. Danaher Corporation Recent Development
Table 95. Siemens Healthcare Company Details
Table 96. Siemens Healthcare Business Overview
Table 97. Siemens Healthcare Medical Biomarkers Product
Table 98. Siemens Healthcare Revenue in Medical Biomarkers Business (2016-2021) & (US$ Million)
Table 99. Siemens Healthcare Recent Development
Table 100. Abbott Company Details
Table 101. Abbott Business Overview
Table 102. Abbott Revenue in Medical Biomarkers Business (2016-2021) & (US$ Million)
Table 103. Abbott Recent Development
Table 104. Agilent Technologies Company Details
Table 105. Agilent Technologies Business Overview
Table 106. Agilent Technologies Medical Biomarkers Product
Table 107. Agilent Technologies Revenue in Medical Biomarkers Business (2016-2021) & (US$ Million)
Table 108. Agilent Technologies Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Medical Biomarkers Market Share by Type: 2020 VS 2027
Figure 2. Sepsis Biomarkers Features
Figure 3. Antibiotic Resistance Biomarkers Features
Figure 4. Traumatic Brain Injury (TBI) Testing Biomarkers Features
Figure 5. Stroke Testing Biomarkers Features
Figure 6. Antibiotic Stewardship Biomarkers Features
Figure 7. Other Features
Figure 8. Global Medical Biomarkers Market Share by Application: 2020 VS 2027
Figure 9. Diagnostics Case Studies
Figure 10. Drug Discovery Case Studies
Figure 11. Personalized Medicine Case Studies
Figure 12. Other Case Studies
Figure 13. Medical Biomarkers Report Years Considered
Figure 14. Global Medical Biomarkers Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Medical Biomarkers Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Medical Biomarkers Market Share by Regions: 2020 VS 2027
Figure 17. Global Medical Biomarkers Market Share by Regions (2022-2027)
Figure 18. Global Medical Biomarkers Market Share by Players in 2020
Figure 19. Global Top Medical Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Biomarkers as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Medical Biomarkers Revenue in 2020
Figure 21. Global Medical Biomarkers Revenue Market Share by Type (2016-2021)
Figure 22. Global Medical Biomarkers Revenue Market Share by Type (2022-2027)
Figure 23. North America Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Medical Biomarkers Market Share by Type (2016-2027)
Figure 25. North America Medical Biomarkers Market Share by Application (2016-2027)
Figure 26. North America Medical Biomarkers Market Share by Country (2016-2027)
Figure 27. United States Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Medical Biomarkers Market Share by Type (2016-2027)
Figure 31. Europe Medical Biomarkers Market Share by Application (2016-2027)
Figure 32. Europe Medical Biomarkers Market Share by Country (2016-2027)
Figure 33. Germany Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Medical Biomarkers Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Medical Biomarkers Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Medical Biomarkers Market Share by Region (2016-2027)
Figure 43. China Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Medical Biomarkers Market Share by Type (2016-2027)
Figure 51. Latin America Medical Biomarkers Market Share by Application (2016-2027)
Figure 52. Latin America Medical Biomarkers Market Share by Country (2016-2027)
Figure 53. Mexico Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Medical Biomarkers Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Medical Biomarkers Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Medical Biomarkers Market Share by Country (2016-2027)
Figure 59. Turkey Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Medical Biomarkers Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Medical Biomarkers Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Medical Biomarkers Business (2016-2021)
Figure 64. Bio-Rad Laboratories Revenue Growth Rate in Medical Biomarkers Business (2016-2021)
Figure 65. QIAGEN Revenue Growth Rate in Medical Biomarkers Business (2016-2021)
Figure 66. Roche Revenue Growth Rate in Medical Biomarkers Business (2016-2021)
Figure 67. Danaher Corporation Revenue Growth Rate in Medical Biomarkers Business (2016-2021)
Figure 68. Siemens Healthcare Revenue Growth Rate in Medical Biomarkers Business (2016-2021)
Figure 69. Abbott Revenue Growth Rate in Medical Biomarkers Business (2016-2021)
Figure 70. Agilent Technologies Revenue Growth Rate in Medical Biomarkers Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---